Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

RMD open·2026
Same author

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Non-Classical Complications of Adult-Onset Still's Disease: A Multicenter Spanish Study.

Journal of clinical medicine·2025
Same author

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.

Arthritis research & therapy·2025
Same author

Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.

Rheumatology international·2024
Same author

Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.

Thorax·2023

Related Experiment Video

Updated: May 26, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Nutrition in systemic sclerosis.

M A Asunción Recasens1, Celia Puig, Vera Ortiz-Santamaria

  • 1Unidad de Endocrinología, Hospital General de Granollers, España.

Reumatologia Clinica
|December 27, 2011
PubMed
Summary

Systemic sclerosis frequently affects the gastrointestinal tract, leading to malnutrition and significant mortality. Multidisciplinary management, including nutritional support, is crucial for improving patient outcomes.

Area of Science:

  • Rheumatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Systemic sclerosis is a multisystem connective tissue disease causing inflammation and fibrosis.
  • Gastrointestinal (GI) tract involvement is common (75-90%) in systemic sclerosis, second only to skin.
  • GI manifestations include dysphagia, reflux, gastroparesis, pseudo-obstruction, bacterial overgrowth, malabsorption, and incontinence.

Purpose of the Study:

  • To highlight the significant impact of gastrointestinal tract involvement in systemic sclerosis.
  • To emphasize the risk of malnutrition and mortality associated with GI complications.
  • To underscore the importance of multidisciplinary management, including nutritional intervention.

Main Methods:

  • Review of existing literature on systemic sclerosis and its gastrointestinal manifestations.

Related Experiment Videos

Last Updated: May 26, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

  • Analysis of the frequency and types of GI involvement.
  • Evaluation of the impact on nutritional status and patient outcomes.

    • Main Results:

    • Gastrointestinal tract is the most affected organ after the skin in systemic sclerosis.
    • Nutritional deficiencies and malnutrition risk affect approximately 30% of patients.
    • GI disorders are a primary cause of death in 5-10% of cases.

    Conclusions:

    • Current therapies for systemic sclerosis primarily manage symptoms.
    • Multidisciplinary care, integrating nutritional intervention, is vital.
    • Improved management can mitigate GI symptoms, prevent malnutrition, reduce morbidity, and enhance quality of life.